Targeting S1P-CFTR signaling, therefore, may emerge as valuable tool to manage cerebrovascular dysfunction, impaired cerebral perfusion, and neuronal injury contributing to HF-associated neurodegeneration and memory deficits. This evidence concerns the gene CFTR and hydrops fetalis.